Table 2.
Annual ARI prevalence categorized by year, type of provider seen, and antibiotic receipta
| Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|---|
| ARI Visits | 70,564,592 | 70,866,608 | 73,615,067 | 78,723,720 | 85,523,707 | 82,353,481 |
| Physician | 66,303,919 (93.9%) | 66,680,009 (94.1%) | 67,972,755 (92.3%) | 71,130,678 (90.4%) | 75,152,677 (87.9%) | 74,249,092 (90.2%) |
| Nurse practitioner | 2,939,945 (4.2%) | 2,665,883 (3.8%) | 4,037,377 (5.5%) | 4,477,586 (5.7%) | 6,999,795 (8.2%) | 5,094,616 (6.2%) |
| Physician assistant | 1,320,728 (1.9%) | 1,520,716 (2.2%) | 1,604,935 2.2%) | 3,115,456 (3.9%) | 3,371,235 (3.9%) | 3,009,773 (3.7%) |
| Received any antibiotic | 10,927,504 (15.5%) | 12,176,720 (17.2%) | 10,087,197 (13.7%) | 12,463,573 (15.8%) | 12,570,746 (14.7%) | 9,748,572 (11.8%) |
| Received broad-spectrum | 7,013,417 (9.9%) | 7,308,493 (10.3%) | 5,988,583 (8.1%) | 7,805,243 (9.9%) | 8,260,365 (9.7%) | 5,329,877 (6.5%) |
Abbreviations: ARI acute respiratory tract infection
a Data presented as number of ARI visits, and number of visits (%)
Broad-spectrum includes: quinolones, macrolides (azithromycin and clarithromycin), amoxicillin/clavulanate, ketolides (oral telithromycin), cephalosporins (2nd and 3rd generations), and clindamycin